iSOFT Wins $14 Million New Business in Europe

iSOFTiSOFT, an IBA Health Group company (ASX: IBA) announced that it has secured new business together with renewal of contracts worth AS$14 million in the UK and central Europe over the past month. iSOFT Northern Europe has had a record month of new orders worth AS$5 million (€3.1 million), while iSOFT UK and Ireland has agreed contract extensions worth AS$9 million (£4.22 million) for ongoing maintenance and support.

New orders for iSOFT Northern Europe included six contracts in Germany for hospital information systems. The company also won four orders for radiology information systems with three hospitals in Germany and with Euromedic in Switzerland for three of its diagnostic centres.

Four contracts for laboratory information systems were also secured with three hospitals in Germany and Gemotest in Russia.

Albertinen Gruppe in Hamburg has agreed a contract for iSOFT's Professional Planner for intelligent financial planning across three sites.

In the UK and Ireland, Harrogate Healthcare NHS Trust and South Tyneside Healthcare NHS Trust have agreed five year licence and support contracts for iSOFT patient management systems and the Southern Health Board in Ireland and St George's Healthcare NHS Trust in London have renewed support agreements for iSOFT laboratory information systems.

Gary Cohen, IBA's Executive Chairman and CEO, said: "We have had an excellent month of new business in Northern Europe, a record for the company and clear evidence of a renewed confidence in iSOFT."

Related news articles:

About IBA Health Group
IBA Health Group Limited (ASX-IBA) is the largest specialist information technology company listed on the Australian Securities Exchange.

IBA builds software applications for healthcare. We work with healthcare professionals to design and build solutions that answer all of the difficult questions posed by today's care delivery challenges. Our solutions act as a catalyst for change, supporting the exchange of critical information across diverse care settings and participant organisations. We are the leader in the provision of advanced application solutions in modern healthcare economies around the world.

Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market and anticipation of evolving requirements. Our business is driven by the collective talent, experience and commitment of over 3,500 healthcare IT experts around the globe.

A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result we offer our customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation and organisational structure.

For more information on IBA Health, please visit the Company's website at www.ibahealth.com.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...